0001479290-22-000034 Sample Contracts

Re: Separation and Consulting Agreement

Revance Therapeutics, Inc. • February 28th, 2022 • Pharmaceutical preparations

• Company
  Revance Therapeutics, Inc.
• Filed
  February 28th, 2022
• Industry
  Pharmaceutical preparations

This letter sets forth the substance of the mutual separation agreement (the “Agreement”) that Revance Therapeutics, Inc. (the “Company”) is offering to you to aid in your employment transition.

Technology Transfer, Validation and Commercial Fill/Finish Services Agreement

Services Agreement • February 28th, 2022 • Revance Therapeutics, Inc. • Pharmaceutical preparations • California

• Contract Type
  Services Agreement
• Filed
  February 28th, 2022
• Company
  Revance Therapeutics, Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  California

This Technology Transfer, Validation and Commercial Fill/Finish Services Agreement (the “Agreement”) is entered into as of the 14th day of March, 2017 (“Effective Date”) by and between Revance Therapeutics, Inc., a Delaware corporation, having its principal place of business at 7555 Gateway Blvd., Newark, CA 94560 (“Client”), and Ajinomoto Althea, Inc., a Delaware corporation, with a place of business located at 11040 Roselle Street, San Diego, CA 92121 (“Althea”);